News

Science 37® and Signant Health Partner to Expand Access to CNS Research with Decentralized Clinical Trials
Science 37® and Signant Health Partner to Expand Access to CNS Research with Decentralized Clinical Trials

Science 37 and Signant Health have announced a partnership to strengthen capabilities for decentralized or virtual CNS clinical research. By bringing research to patients at home, the partnership w...

CONTINUE
Science 37® Supports DCRI's First Direct-to-Family Study for Pediatric Lupus
Science 37® Supports DCRI's First Direct-to-Family Study for Pediatric Lupus

Science 37 is excited to be part of the first-of-its-kind direct-to-family study with the Duke Clinical Research Institute (DCRI) for decentralized research in pediatric lupus. The iPERSONAL (Indiv...

CONTINUE
Science 37® Integrates Electronic Health Records into Its Decentralized Clinical Trial Technology Platform
Science 37® Integrates Electronic Health Records into Its Decentralized Clinical Trial Technology Platform

Patients using Science 37's technology platform can now connect their health record directly, in real time, eliminating paper documentation and streamlining information sharing LOS ANGELES, Sep...

CONTINUE
John Hubbard, Ph.D., Joins Science 37® Board of Directors
John Hubbard, Ph.D., Joins Science 37® Board of Directors

LOS ANGELES, September 2, 2020 -  Science 37, the industry leader in decentralized clinical trials, today announced the appointment of industry veteran John Hubbard, Ph.D., FCP to its Board of...

CONTINUE
ERT and Science 37® Partner to Deliver High-Quality Data during Virtual Trials
ERT and Science 37® Partner to Deliver High-Quality Data during Virtual Trials

Technology partnership enables trial sponsors to improve imaging, respiratory, and cardiac safety data quality while reducing patient burden and risk.   PHILADELPHIA & LOS ANGELES, August ...

CONTINUE
Science 37® Raises $40 Million to Extend Its Leadership in the Decentralized Clinical Trial Market
Science 37® Raises $40 Million to Extend Its Leadership in the Decentralized Clinical Trial Market

In a significantly oversubscribed offering, Science 37 attracted capital to support its rapid growth, expand its technology platform, and accelerate global expansion. LOS ANGELES, August 20, 2020 -...

CONTINUE
Science 37® Named to 2020 CB Insights Digital Health 150 List of Most Innovative Digital Health Start-Ups
Science 37® Named to 2020 CB Insights Digital Health 150 List of Most Innovative Digital Health Start-Ups

Science 37, the industry leader in decentralized clinical trials, has been named to the Digital Health 150, CB Insights' annual ranking of the most promising digital health companies in the world.

CONTINUE
Science 37® and Advarra Detail Methods for Research Continuity
Science 37® and Advarra Detail Methods for Research Continuity

A new whitepaper from Science 37 and Advarra explores how research is continuing in the COVID-19 era.   Although many nations appear to have turned the tide in the current global pandemic, the...

CONTINUE
Science 37® Furthers Global Expansion and Decentralized Trial Leadership
Science 37® Furthers Global Expansion and Decentralized Trial Leadership

Science 37 adds to its industry-leading virtual trial capabilities in Europe, South America, and Asia-Pacific.-- LOS ANGELES, July 28, 2020 - Science 37, the industry leader in decentralized clinic...

CONTINUE
Science 37® Appoints Mike Zaranek as Chief Financial Officer
Science 37® Appoints Mike Zaranek as Chief Financial Officer

Executive role applies financial rigor to ensure profitable growth as the company continues to scale. LOS ANGELES, May 19, 2020 - Science 37, the industry leader in virtual clinical trials, announc...

CONTINUE
Science 37® and AiCure Partner to Enhance Virtual Clinical Trials
Science 37® and AiCure Partner to Enhance Virtual Clinical Trials

The partnership combines artificial intelligence with comprehensive virtual trial services to bring novel insights to research. LOS ANGELES & NEW YORK, April 30, 2020 - Science 37, the industry...

CONTINUE
Science 37® Partners with Advarra to Expedite Virtual Trial Research for COVID-19
Science 37® Partners with Advarra to Expedite Virtual Trial Research for COVID-19

The partnership addresses key concerns for clinical trial sponsors as they transition to virtual trials in light of the COVID-19 pandemic.-- LOS ANGELES & COLUMBIA, Md., April 21, 2020 - Scienc...

CONTINUE
Page 1 of 2
12